3Sotiris KH, Klaus J, Markus S. Novel organotin (IV) compounds derived from his ( organostannyl ) methanes: Synthesis and crystal structures of his E diphenyl ( pyridin-2- onato) stannyl] methane and his I bromophenyl( pyrimidine- 2-thionato) stannyl ] methane . CTH8 E J 1. J Organomet Chem, 2006, 691 (8): 1637-1642.
4Hideaki I, Motohiro K, Hisao M, et al. Inhibitory Effects of Organotin Compounds on Histamine Release from Rat Serosal Mast Cells [J]. Ind Health, 1992, 30(2) : 77-84.
5R 8hl C, Grell M, Maser E. The organotin compounds trimethyhin (TMT) and triethyhin (TET) but not tributyltin (TBT) induce activation of microglia co- cultivated with astrocytes [J]. Toxicol in Vitro, 2009, 23 (8) : 1541-1547.
6Li YL, Liu JJ, Yang L, et al. Mechanisms by which the Antitumor Compound Di-n-butyl-di-(4-chlorobenzohydroxamato) tin(IV) Induces Apoptosis and the Mitochondrial-Mediated Signaling Pathway in Human Cancer SGC-7901 Cells [J]. Mol Carcinogen, 2010, 49(6) : 566-581.
7Zhang YX, Li YL, Li QS. Inhibition of Cytochrome P450 3A in Rat Liver by the Diorganotin (IV) Compound di-n- Butyl-di-(4-chlorobenzohydroxamato ) tin ( IV ) and Its Probable Mechanism [J]. Molecules, 2012, 17 (9) : 10994-11009.
8Tang L, Li YL, Ge R, et al. Oxidative stress in di-n-butyl-di-( 4-chlorobenzohydroxamato ) tin ( IV )-induced hepatotoxicity determined by proteomic profiles [ J ]. Toxicol Lett. 2012. 213(2) : 167-173.
